Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.

[1]  B. Nare,et al.  Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase. , 2006, Molecular and biochemical parasitology.

[2]  D. Schmatz,et al.  Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents. , 2006, Bioorganic & medicinal chemistry letters.

[3]  Michael P Barrett,et al.  Chemotherapy of trypanosomiases and leishmaniasis. , 2005, Trends in parasitology.

[4]  D. Schmatz,et al.  Hydroxylated N-alkyl-4-piperidinyl-2,3-diarylpyrrole derivatives as potent broad-spectrum anticoccidial agents. , 2005, Bioorganic & medicinal chemistry letters.

[5]  D. Schmatz,et al.  Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents. , 2005, Bioorganic & medicinal chemistry letters.

[6]  Andreas Gocht,et al.  The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. , 2005, Cellular signalling.

[7]  L. Meijer,et al.  Characterization of two T. gondii CK1 isoforms. , 2005, Molecular and biochemical parasitology.

[8]  J. Bubis,et al.  Identification of casein kinase 1, casein kinase 2, and cAMP-dependent protein kinase-like activities in Trypanosoma evansi. , 2004, Memorias do Instituto Oswaldo Cruz.

[9]  D. Vetrie,et al.  Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. , 2004, Molecular and biochemical parasitology.

[10]  L. Sibley,et al.  A role for coccidian cGMP-dependent protein kinase in motility and invasion. , 2004, International journal for parasitology.

[11]  J. Bubis,et al.  Protein Kinase CK1 from Trypanosoma cruzi , 2003, Journal of protein chemistry.

[12]  S. Croft,et al.  Leishmaniasis: new approaches to disease control , 2003, BMJ : British Medical Journal.

[13]  S. Castanys,et al.  Two casein kinase 1 isoforms are differentially expressed in Trypanosoma cruzi. , 2002, Molecular and biochemical parasitology.

[14]  Shyam Sundar,et al.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. , 2002, The Lancet. Infectious diseases.

[15]  C. Jaffe,et al.  Effect of pH and temperature on protein kinase release by Leishmania donovani. , 2002, International journal for parasitology.

[16]  B. Nare,et al.  Toxoplasma gondii Cyclic GMP-Dependent Kinase: Chemotherapeutic Targeting of an Essential Parasite Protein Kinase , 2002, Eukaryotic Cell.

[17]  Jeffrey Yuan,et al.  Purification and Molecular Characterization of cGMP-dependent Protein Kinase from Apicomplexan Parasites , 2002, The Journal of Biological Chemistry.

[18]  P. Liberator,et al.  Molecular characterization of a coccidian parasite cGMP dependent protein kinase. , 2002, Molecular and biochemical parasitology.

[19]  P. Liberator,et al.  The role of a parasite-specific allosteric site in the distinctive activation behavior of Eimeria tenella cGMP-dependent protein kinase. , 2002, Biochemistry.

[20]  J. Wilkesman,et al.  Biochemical and enzymatic characterization of a partially purified casein kinase-1 like activity from Trypanosoma cruzi. , 2002, Parasitology international.

[21]  B. Nare,et al.  Evaluation of a Cyclic GMP-Dependent Protein Kinase Inhibitor in Treatment of Murine Toxoplasmosis: Gamma Interferon Is Required for Efficacy , 2002, Antimicrobial Agents and Chemotherapy.

[22]  S. Sundar,et al.  Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J Mottram,et al.  Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. , 2000, Chemistry & biology.

[24]  F. Pratlong,et al.  Leishmania, Trypanosoma and Monoxenous Trypanosomatids as Emerging Opportunistic Agents1 , 2000, The Journal of eukaryotic microbiology.

[25]  S. D. Gross,et al.  Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. , 1998, Cellular signalling.

[26]  E. A. O'neill,et al.  Molecular basis for p38 protein kinase inhibitor specificity. , 1998, Biochemistry.

[27]  M. Maccoss,et al.  Pyrroles and other heterocycles as inhibitors of p38 kinase. , 1998, Bioorganic & medicinal chemistry letters.

[28]  S H Kim,et al.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.

[29]  Elizabeth J. Goldsmith,et al.  Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding Pocket* , 1998, The Journal of Biological Chemistry.

[30]  C. Jaffe,et al.  Release of Ecto-protein Kinases by the Protozoan ParasiteLeishmania major* , 1997, The Journal of Biological Chemistry.

[31]  D. Chakrabarti,et al.  Identification, Cloning, and Mutational Analysis of the Casein Kinase 1 cDNA of the Malaria Parasite, Plasmodium falciparum , 1997, The Journal of Biological Chemistry.

[32]  N. Suzuki,et al.  Cultivation of bloodstream forms of Trypanosoma brucei and T. evansi in a serum‐free medium , 1997 .

[33]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[34]  S. I. Becker,et al.  Leishmanial protein kinases phosphorylate components of the complement system. , 1991, The EMBO journal.

[35]  R. Brown,et al.  Protein measurement using bicinchoninic acid: elimination of interfering substances. , 1989, Analytical biochemistry.

[36]  D. Iovannisci,et al.  High efficiency plating method for Leishmania promastigotes in semidefined or completely-defined medium. , 1983, The Journal of parasitology.